Innate Pharma SA (IPHYF)
2.20
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
Innate Pharma Total Assets (Quarterly): 203.61M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 203.61M |
| June 30, 2023 | 216.31M |
| June 30, 2023 | 216.31M |
| December 31, 2022 | 222.91M |
| June 30, 2022 | 292.93M |
| June 30, 2022 | 292.93M |
| December 31, 2021 | 302.86M |
| June 30, 2021 | 316.81M |
| June 30, 2021 | 316.81M |
| December 31, 2020 | 378.12M |
| June 30, 2020 | 374.59M |
| June 30, 2020 | 374.59M |
| December 31, 2019 | 449.59M |
| June 30, 2019 | 400.86M |
| June 30, 2019 | 400.86M |
| December 31, 2018 | 516.15M |
| June 30, 2018 | 261.21M |
| June 30, 2018 | 261.21M |
| December 31, 2017 | 305.95M |
| June 30, 2017 | 281.85M |
| June 30, 2017 | 281.85M |
| Date | Value |
|---|---|
| December 31, 2016 | 297.67M |
| June 30, 2016 | 314.08M |
| June 30, 2016 | 314.08M |
| December 31, 2015 | 334.50M |
| June 30, 2015 | 342.18M |
| June 30, 2015 | 342.18M |
| December 31, 2014 | 110.28M |
| June 30, 2014 | 141.16M |
| June 30, 2014 | 141.16M |
| December 31, 2013 | 77.17M |
| June 30, 2013 | 54.50M |
| June 30, 2013 | 54.50M |
| December 31, 2012 | 63.87M |
| June 30, 2012 | 69.44M |
| June 30, 2012 | 69.44M |
| December 31, 2011 | 77.86M |
| June 30, 2011 | 60.05M |
| December 31, 2010 | 63.85M |
| June 30, 2010 | 67.61M |
| December 31, 2009 | 91.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
203.61M
Minimum
Dec 2023
449.59M
Maximum
Dec 2019
317.34M
Average
316.81M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 182.99M |
| Cellectis SA | 334.27M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 192.20M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 146.24M |
| Shareholders Equity (Quarterly) | 57.37M |
| Debt to Equity Ratio | 0.7525 |
| Current Ratio | 3.734 |
| Net Debt Paydown Yield | 0.31% |